Gilead Sciences, Inc.
GILD
$134.43
-$1.79-1.31%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.42% | -28.47% | 55.71% | 49.05% | -26.25% |
| Total Depreciation and Amortization | 0.29% | 0.15% | -0.72% | -0.72% | 0.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.63% | 59.07% | 251.05% | -75.61% | 4,768.75% |
| Change in Net Operating Assets | -17.72% | -103.37% | 85.25% | -94.97% | -313.87% |
| Cash from Operations | -23.53% | -19.01% | 396.74% | -52.93% | -40.94% |
| Capital Expenditure | 42.93% | -39.46% | -37.38% | -2.88% | 29.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 82.10% | -264.67% | -695.24% | 92.31% | -264.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 295.49% | -803.54% | 94.32% | -5,131.58% | -1,166.67% |
| Cash from Investing | 196.46% | -329.74% | 79.82% | -409.88% | -84.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34,475.00% | 11.11% | 0.00% | 99.49% | -25,071.43% |
| Issuance of Common Stock | 418.75% | -67.01% | 259.26% | -89.29% | 45.66% |
| Repurchase of Common Stock | -82.17% | 47.13% | 17.46% | 27.81% | -108.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.63% | 1.09% | -1.11% | 1.58% | -3.80% |
| Other Financing Activities | -185.71% | 54.01% | -114.06% | 63.64% | -274.47% |
| Cash from Financing | -235.63% | 15.18% | 4.98% | 54.26% | -251.59% |
| Foreign Exchange rate Adjustments | -320.00% | 200.00% | -106.85% | 284.21% | 134.55% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -200.00% | -- | -- |
| Net Change in Cash | -72.22% | -89.30% | 178.58% | -34.72% | -141.68% |